secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001437749-23-007120
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo expects Q1 2023 revenue >4x YoY, seventh consecutive quarterly growth record
--------------------------------------------------------------------------------

- Q1 2023 preliminary revenues expected to surpass Q4 2022 record; QoQ growth >50%.
- Revenue driven by Pooph pet-odor product from Ikigai Marketing Works.
- Company not yet profitable but net losses trending down as revenue increases.
- 2022 preliminary YoY revenue growth at least 125%; eighth consecutive annual growth.
- Company expects to file 2022 annual report by end of March; earnings call April 3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/0001437749-23-007120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/blgo20230317_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-007120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer